Public-registry trials using Oxycodone extended-release that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain | Egalet Ltd | Moderate-to-severe Chronic Noncancer Pain | PHASE3 | 39 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →